Cancer Vaccines: Adjuvant Potency, Importance of Age, Lifestyle, and Treatments
Although the discovery and characterization of multiple tumor antigens have sparked the development of many antigen/derived cancer vaccines, many are poorly immunogenic and thus, lack clinical efficacy. Adjuvants are therefore incorporated into vaccine formulations to trigger strong and long-lasting...
Main Authors: | Stefania Cuzzubbo, Sara Mangsbo, Divya Nagarajan, Kinana Habra, Alan Graham Pockley, Stephanie E. B. McArdle |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-02-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2020.615240/full |
Similar Items
-
Robust formation of optimal single spheroids towards cost‐effective in vitro three‐dimensional tumor models
by: Kinana Habra, et al.
Published: (2023-07-01) -
Editorial: Frontiers’ Research Topic “Cancer Vaccines: Time to Think Differently!”
by: Stephanie E. B. McArdle, et al.
Published: (2021-10-01) -
Synthesis and Functionalisation of Superparamagnetic Nano-Rods towards the Treatment of Glioblastoma Brain Tumours
by: Kinana Habra, et al.
Published: (2021-08-01) -
Immune Escape in Glioblastoma Multiforme and the Adaptation of Immunotherapies for Treatment
by: Joshua R. D. Pearson, et al.
Published: (2020-10-01) -
A Novel HAGE/WT1-ImmunoBody® Vaccine Combination Enhances Anti-Tumour Responses When Compared to Either Vaccine Alone
by: Rukaia Almshayakhchi, et al.
Published: (2021-06-01)